Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

ProPhase Labs ROE 2010-2025 | PRPH

Current and historical return on equity (ROE) values for ProPhase Labs (PRPH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
ProPhase Labs ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.04B $0.02B -165.38%
2024-12-31 $-0.05B $0.01B -158.21%
2024-09-30 $-0.03B $0.04B -63.64%
2024-06-30 $-0.03B $0.04B -53.61%
2024-03-31 $-0.02B $0.05B -44.02%
2023-12-31 $-0.02B $0.05B -28.57%
2023-09-30 $-0.01B $0.06B -15.06%
2023-06-30 $0.00B $0.06B -4.78%
2023-03-31 $0.01B $0.06B 10.77%
2022-12-31 $0.02B $0.06B 27.07%
2022-09-30 $0.03B $0.07B 47.51%
2022-06-30 $0.03B $0.07B 43.15%
2022-03-31 $0.02B $0.07B 32.58%
2021-12-31 $0.01B $0.06B 13.46%
2021-09-30 $-0.01B $0.05B -12.50%
2021-06-30 $0.00B $0.05B -3.25%
2021-03-31 $0.00B $0.05B 0.00%
2020-12-31 $0.00B $0.01B -18.18%
2020-09-30 $0.00B $0.01B -9.09%
2020-06-30 $0.00B $0.01B -8.51%
2020-03-31 $0.00B $0.01B -15.69%
2019-12-31 $0.00B $0.01B -14.29%
2019-09-30 $0.00B $0.01B -12.90%
2019-06-30 $0.00B $0.02B -17.65%
2019-03-31 $0.00B $0.02B -10.81%
2018-12-31 $0.00B $0.02B -4.44%
2018-09-30 $0.00B $0.02B -3.81%
2018-06-30 $0.00B $0.02B -3.31%
2018-03-31 $0.00B $0.03B -8.22%
2017-12-31 $0.04B $0.03B 100.00%
2017-09-30 $0.04B $0.04B 115.94%
2017-06-30 $0.04B $0.05B 150.46%
2017-03-31 $0.04B $0.05B 243.48%
2016-12-31 $0.00B $0.01B -46.15%
2016-09-30 $0.00B $0.01B -41.38%
2016-06-30 $0.00B $0.01B -25.00%
2016-03-31 $0.00B $0.01B -35.29%
2015-12-31 $0.00B $0.01B -33.33%
2015-09-30 $0.00B $0.01B -31.58%
2015-06-30 $-0.01B $0.01B -71.79%
2015-03-31 $-0.01B $0.01B -71.11%
2014-12-31 $-0.01B $0.01B -65.31%
2014-09-30 $-0.01B $0.01B -47.06%
2014-06-30 $0.00B $0.01B -15.38%
2014-03-31 $0.00B $0.01B -8.33%
2013-12-31 $0.00B $0.01B 0.00%
2013-09-30 $0.00B $0.01B -8.89%
2013-06-30 $0.00B $0.01B -9.30%
2013-03-31 $0.00B $0.01B -9.52%
2012-12-31 $0.00B $0.01B -19.51%
2012-09-30 $0.00B $0.01B -39.02%
2012-06-30 $0.00B $0.01B -36.36%
2012-03-31 $0.00B $0.01B -25.53%
2011-12-31 $0.00B $0.01B -24.49%
2011-09-30 $0.00B $0.01B -15.69%
2011-06-30 $0.00B $0.01B -15.38%
2011-03-31 $0.00B $0.01B -22.64%
2010-12-31 $0.00B $0.01B -21.43%
2010-09-30 $0.00B $0.01B 0.00%
2010-06-30 $0.00B $0.01B 0.00%
2010-03-31 $0.00B $0.02B -22.64%
2009-12-31 $0.00B $0.01B -30.19%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.015B $0.007B
ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE?, a zinc gluconate glycine product. COLD-EEZE? family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.750B 26.44
Zoetis (ZTS) United States $66.376B 24.08
Takeda Pharmaceutical (TAK) Japan $46.552B 9.50
Daiichi Sankyo, - (DSNKY) Japan $46.222B 23.69
BeOne Medicines - (ONC) Switzerland $31.576B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.096B 0.00
Summit Therapeutics (SMMT) United States $19.080B 0.00
Merck (MKKGY) Germany $16.874B 10.97
Shionogi (SGIOY) Japan $15.432B 15.46
United Therapeutics (UTHR) United States $13.595B 11.76
Neurocrine Biosciences (NBIX) United States $12.784B 38.13
Orion OYJ (ORINY) Finland $10.848B 26.14
IPSEN (IPSEY) France $10.440B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.971B 0.00
Corcept Therapeutics (CORT) United States $7.754B 65.12
Grifols, S.A (GRFS) Spain $7.288B 0.00
Stevanato Group S.p.A (STVN) Italy $6.611B 38.98
Ionis Pharmaceuticals (IONS) United States $6.600B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.317B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.141B 17.65
Soleno Therapeutics (SLNO) United States $4.430B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.827B 13.46
NewAmsterdam Pharma (NAMS) Netherlands $2.807B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.682B 0.00
Hypermarcas (HYPMY) Brazil $2.579B 19.39
Catalyst Pharmaceuticals (CPRX) United States $2.489B 8.34
Centessa Pharmaceuticals (CNTA) United Kingdom $2.286B 0.00
Ocular Therapeutix (OCUL) United States $2.171B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.753B 0.00
Dyne Therapeutics (DYN) United States $1.653B 0.00
ARS Pharmaceuticals (SPRY) United States $1.636B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.490B 22.20
Guardian Pharmacy Services (GRDN) United States $1.432B 0.00
Evotec AG (EVO) Germany $1.353B 0.00
Ardelyx (ARDX) United States $1.350B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.296B 0.00
Harrow (HROW) United States $1.289B 0.00
Collegium Pharmaceutical (COLL) United States $1.193B 6.52
Xeris Biopharma Holdings (XERS) United States $1.179B 0.00
Cronos Group (CRON) Canada $0.983B 0.00
Enliven Therapeutics (ELVN) United States $0.927B 0.00
Akebia Therapeutics (AKBA) United States $0.880B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.731B 0.00
Siga Technologies (SIGA) United States $0.666B 8.23
ProKidney (PROK) United States $0.656B 0.00
Zevra Therapeutics (ZVRA) United States $0.643B 0.00
Organogenesis (ORGO) United States $0.620B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.619B 6.38
KalVista Pharmaceuticals (KALV) United States $0.612B 0.00
Elite Pharmaceuticals (ELTP) United States $0.608B 0.00
Bioventus (BVS) United States $0.600B 14.62
Theravance Biopharma (TBPH) United States $0.596B 49.67
Relay Therapeutics (RLAY) United States $0.578B 0.00
Xencor (XNCR) United States $0.553B 0.00
Tourmaline Bio (TRML) United States $0.552B 0.00
USANA Health Sciences (USNA) United States $0.549B 11.26
Tonix Pharmaceuticals Holding (TNXP) United States $0.524B 0.00
Oruka Therapeutics (ORKA) United States $0.522B 0.00
Savara (SVRA) United States $0.446B 0.00
Aquestive Therapeutics (AQST) United States $0.377B 0.00
Esperion Therapeutics (ESPR) United States $0.355B 0.00
Nanobiotix S.A (NBTX) France $0.355B 0.00
Aldeyra Therapeutics (ALDX) United States $0.321B 0.00
Larimar Therapeutics (LRMR) United States $0.306B 0.00
Altimmune (ALT) United States $0.294B 0.00
Nektar Therapeutics (NKTR) United States $0.293B 0.00
4D Molecular Therapeutics (FDMT) United States $0.287B 0.00
Nature's Sunshine Products (NATR) United States $0.287B 18.71
AleAnna (ANNA) United States $0.287B 0.00
OmniAb (OABI) United States $0.239B 0.00
Galectin Therapeutics (GALT) United States $0.239B 0.00
MediWound (MDWD) Israel $0.203B 0.00
Heron Therapeutics (HRTX) United States $0.201B 0.00
Journey Medical (DERM) United States $0.199B 0.00
China SXT Pharmaceuticals (SXTC) China $0.181B 0.00
Aclaris Therapeutics (ACRS) United States $0.178B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
Profound Medical (PROF) Canada $0.167B 0.00
Lyell Immunopharma (LYEL) United States $0.163B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.159B 24.56
MEI Pharma (MEIP) United States $0.155B 0.00
Lexeo Therapeutics (LXEO) United States $0.155B 0.00
Korro Bio (KRRO) United States $0.150B 0.00
Avita Medical (RCEL) United States $0.147B 0.00
Inhibikase Therapeutics (IKT) United States $0.130B 0.00
Avalo Therapeutics (AVTX) United States $0.123B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Liminatus Pharma (LIMN) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.112B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.110B 0.00
Dominari Holdings (DOMH) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
Surrozen (SRZN) United States $0.091B 0.00
Champions Oncology (CSBR) United States $0.090B 20.41
VAXART, INC (VXRT) United States $0.087B 0.00
ESSA Pharma (EPIX) Canada $0.085B 0.00
Achieve Life Sciences (ACHV) Canada $0.085B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Assertio Holdings (ASRT) United States $0.079B 0.00
BioNxt Solutions (BNXTF) Canada $0.079B 0.00
Nutriband (NTRB) United States $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Metagenomi (MGX) United States $0.070B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Pyxis Oncology (PYXS) United States $0.064B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.061B 0.00
DURECT (DRRX) United States $0.059B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.054B 0.00
Unicycive Therapeutics (UNCY) United States $0.054B 0.00
Wellgistics Health (WGRX) United States $0.054B 0.00
Fractyl Health (GUTS) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.047B 0.00
Telomir Pharmaceuticals (TELO) United States $0.046B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Plus Therapeutics (PSTV) United States $0.044B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.044B 26.45
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Tempest Therapeutics (TPST) United States $0.039B 0.00
FibroGen (FGEN) United States $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.037B 0.00
Enlivex Therapeutics (ENLV) Israel $0.037B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Iterum Therapeutics (ITRM) Ireland $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Mural Oncology (MURA) Ireland $0.029B 0.00
Vivos Therapeutics (VVOS) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Citius Pharmaceuticals (CTXR) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
BioVie (BIVI) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 12.83
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.15
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00